500 related articles for article (PubMed ID: 15537844)
21. Treatment of hypertension in patients with diabetes.
Sowers JR
Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759
[TBL] [Abstract][Full Text] [Related]
22. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
23. Practical problems in the management of hypertension in the diabetic patient.
O'Hare JP
J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
[No Abstract] [Full Text] [Related]
24. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
Esnault V
Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
[TBL] [Abstract][Full Text] [Related]
25. Preventing end-stage renal disease.
Mogensen CE
Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
[TBL] [Abstract][Full Text] [Related]
26. Hypertension and microalbuminuria as predictors of diabetic nephropathy.
Jones SL; Viberti GC
Diabete Metab; 1989; 15(5 Pt 2):327-32. PubMed ID: 2612717
[TBL] [Abstract][Full Text] [Related]
27. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
28. Diabetic nephropathy in children with type 1 diabetes mellitus in Bahrain.
Al-Hermi BE; Al-Abbasi AM; Rajab MH; Al-Jenaidi FA; Al-Ekri ZE
Saudi Med J; 2005 Feb; 26(2):294-7. PubMed ID: 15770309
[TBL] [Abstract][Full Text] [Related]
29. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Haller H; Viberti GC; Mimran A; Remuzzi G; Rabelink AJ; Ritz E; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Januszewicz A
J Hypertens; 2006 Feb; 24(2):403-8. PubMed ID: 16508590
[TBL] [Abstract][Full Text] [Related]
30. Albuminuria and diabetic nephropathy.
Chang SS
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
[TBL] [Abstract][Full Text] [Related]
31. Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
McCullough PA; Bakris GL; Owen WF; Klassen PS; Califf RM
Am Heart J; 2004 Aug; 148(2):243-51. PubMed ID: 15308993
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
[TBL] [Abstract][Full Text] [Related]
33. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
Conti AA
Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
[TBL] [Abstract][Full Text] [Related]
34. [Early detection and control of risk factors in diabetic nephropathy].
Fernández López MT; Isidro San Juan ML; Cordido F
An Med Interna; 1998 Nov; 15(11):600-5. PubMed ID: 9882860
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
36. Determinants of progressive renal disease in diabetes mellitus.
Aurell M; Björck S
Kidney Int Suppl; 1992 May; 36():S38-42. PubMed ID: 1614066
[TBL] [Abstract][Full Text] [Related]
37. Microalbuminuria and associated factors in newly diagnosed diabetics.
Unuigbe EI; Omeife H; Edema T; Ukoli FA
Niger Postgrad Med J; 2001 Dec; 8(4):187-92. PubMed ID: 11922026
[TBL] [Abstract][Full Text] [Related]
38. [Recommendations for the management of diabetic patients with nephropathy].
Rupprecht H; Piehlmeier W
MMW Fortschr Med; 2005 May; 147(21):43-6. PubMed ID: 15966171
[TBL] [Abstract][Full Text] [Related]
39. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
[TBL] [Abstract][Full Text] [Related]
40. [Nephropathy in non-insulin-dependent (type-2) diabetes mellitus].
Nagy J; Wittmann I
Orv Hetil; 2000 Mar; 141(12):609-14. PubMed ID: 10769544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
